chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was inadvertently given 0.1ml of Janssen Covid 19 vaccine intradermally left lower forearm. 2 days later patient has cellulitis symptoms at area of injection, and reports worsening daily. Treated with antibiotic course, started today, Keflex 500mg PO 4x daily x 10 days. No other systemic issues, only localized.
This case was reported by a nurse via call center representative and described the occurrence of Bell's palsy in a 6-year-old male patient who received Influenza vaccine Quadrivalent. Concurrent medical conditions included local swelling (which was believed to be viral). On 12th October 2017, the patient received Influenza vaccine Quadrivalent. On 15th October 2017, 3 days after receiving Influenza vaccine Quadrivalent, the patient experienced Bell's palsy (serious criteria GSK medically significant). On 16th October 2017, the patient experienced Lyme disease (serious criteria GSK medically significant). The patient was treated with erythromycin, Steroids, Artificial Tears and TYLENOL. On an unknown date, the outcome of the Bell's palsy was recovered/resolved and the outcome of the Lyme disease was unknown. It was unknown if the reporter considered the Bell's palsy and Lyme disease to be related to Influenza vaccine Quadrivalent. Additional details were provided as follows: On 11th October 2017, the patient had a lump on their neck. On 15th October 2017, at home the patient was applied moist heat. On 16th October 2017, 4 days after receiving Influenza vaccine Quadrivalent, the patient had blood work and tested positive for Lyme disease. The Bell's palsy resolved, without any further medical intervention, or hospitalization, and the patient's symptoms were not considered disabling, or life threatening. The healthcare professional was unsure of which brand flu vaccine the patient received as the vaccine was administered by the patient's school.
Bilateral cellulitis of lower extremities. 18x3.5 cm of erythema and some induration and warmth over lateral left thigh. Lateral right thigh 3x3 erythematous area. Augmentin prescribed for treatment.
Patient experienced BALANCE ISSUES resulting in him bumping into things. He also felt very sick. Experienced symptoms for about 24 hours
On 9/30, DOH was notified by an health services company that a nurse had reused syringes for multiple persons earlier that day at am employee influenza vaccination clinic where the health services company had been contracted. The nurse contracted by the health services company brought three multiple-dose vials of vaccine that were intended for another event (and stored in her personal fridge without temp monitoring). The nurse reported using two syringes she found among her supplies to administer vaccine to 67 employees of the business. She reported wiping  the syringes with alcohol and using a new needle for each of the 67 persons. Only 2 multiple dose vials of vaccine (10 doses/vial) were used for 67 adult participants. Participants were offered blood borne pathogen testing (hep N, hep C, HIV), hepatitis B vaccine, and flu vaccine.
1 week after 1st shot, small red spots appeared on legs, feet, thighs, neck, and chest. Along with unusally easy bruising on legs and thighs. These symptoms of spots and bruising still remain today.. Some blood after blowing nose for a few days.  Pain in injection arm from wrist to shoulder and in armpit for a couple of days 1 week after shot.
Pt sister reported that: Pt. after receiving the first dose had a severe allergic reaction within minutes of being vaccinated and required an ambulance and was transported to Hospital ED and then discharged. Them her sister said she was taken later to another hospital where she was admitted to the ICU. She said her sister was later discharged but is "still having seizures".   Note: our clinic staff that observe patients with no allergy history for the minimum recommended time of 15 minutes post vaccination  do not have any recollection of an allergic reaction or an ambulance coming to clinic to transport this patient.
feeling like his heart was racing, Vitals stable. HR=74; This is a spontaneous report from a Pfizer Colleague's Immediate Family and Household Vaccination Program via a contactable consumer (patient). A male patient of an unspecified age received BNT162B2 (PFIZER COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient complained of feeling like his heart was racing, vitals stable and heart rate (HR) was 74 on an unspecified date. The patient sat for a bit and then said he was good. The patient was suggested to follow up with the primary care physician if the symptoms return. The outcome of the event was recovered at the reporting time.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Chills and feeling freezing; Vomitting; Abdominal pain; Difficulty breathing; Fever; A spontaneous report, was received from a consumer (patient's wife), concerning her husband, a 64 years-old male patient, unknown race and ethnicity, who was administered Moderna's COVID-19 vaccine (mRNA-1273), and experienced chills and feeling freezing (chills), vomiting, abdominal pain, difficulty breathing (dyspnoea) and fever (pyrexia).  The patient's medical history included history of congestive heart failure; triple bypass surgery done in 2017. The patient received dialysis on (Mon, Wed, & Fri), and was on oxygen 24 hours a day. The patient has allergy to valsartan and morphine. No Relevant concomitant medications were reported.  On 11 Mar 2021, approximately within one hour prior to the onset of events, the patient received their first of two planned doses of mRNA-1273 (Lot number: Unknown) intramuscularly in the right arm for prophylaxis of COVID-19 infection.   On 11 Mar 2021, while at home, within an hour of receiving the vaccine, the patient started to experience chills and feeling freezing. The patient was taken to the hospital. The patient also experienced vomiting, complained of chills, developed abdominal pain, and had difficulty in breathing. The patient was currently in the intensive care unit. The patient's carbon level was high, needed a pit line and under bypap. The patient also had developed fever. Treatment medications included unspecified antibiotics and bilevel positive airway pressure (BiPAP) given to the patient at the hospital.  Action taken with second dose of mRNA-1273 in response to the events was unknown.  The outcome of the events, chills and feeling freezing, vomiting, abdominal pain, difficulty breathing, fever were considered as unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
2 weeks after second does same reaction on stomach and leg but symptoms less severe.; small blisters; the rash is red; itch; hurt; small lessons appeared; Fever of 101; swollen lymph nodes in my neck; This is a spontaneous report from a contactable consumer. A 63-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6204), via intramuscular route, administered in Arm Left on 09Apr2021 as DOSE 2, SINGLE for covid-19 immunisation (at the age of 63 years). Previously patient took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN-6198) in 12Mar2021.Patient is not pregnant at the time of vaccination. The patient medical history was not reported. There were no concomitant medications. Received no other vaccine in four weeks. No other medications in two weeks. The patient experienced 2 weeks after second does same reaction on stomach and leg but symptoms less severe, small blisters, the rash is red, itch, hurt, small lessons appeared, fever of 101, swollen lymph nodes in my neck on an unspecified date. It was reported that 2 weeks after first does developed rash on thigh which looked and felt like shingles. dot worse for two weeks spreading in the area. painful and itchy. started to resolve after 3 weeks. 2 weeks after second does same reaction on stomach and leg but symptoms less severe. started to resolve after a week. 3 weeks after second dose more small lessons appeared. the rash is red raised with small blisters that itch and hurt. they dried up after 3 weeks. 2 weeks after each vaccine she developed a rash with blisters forming after 5-7 days. The rash lasted approximately 3 weeks each time the blisters started to dry up after 2 weeks the rash got worse for approximately 2 weeks. It itched and was painful incisures (unclear meaning) consistent with shingles virus. 3 weeks after the second vaccine she developed a fever of 101 for 2 days and swollen lymph nodes in my neck which lasted for 3-2 weeks. The adverse event resulted in clinic visit. No covid prior vaccination. Covid tested post vaccination. Covid test type post vaccination was nasal swab. The patient underwent lab tests which included body temperature: 101 No units provided and sars-cov-2 test: negative on 26Apr2021. No treatment received. The clinical outcome of the events were not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt vax w/ 3 doses; antibody level 7.2 below therapeutic level.  2 addit doses admin, resulted in an antibody level 81.2.
4JUN98 1140AM pt recv vax & vomited in room, twitched x 2-3sec;went limp, no LOC;pale, forehead diaphoretic, HR 50-60, BP 60/40;02 given by mask;HR 80's, BP 88/50;remained oriented;hosp for observation;
Severe arm pain of the arm injection was in immediately following injection and for 1 week afterwards. Patient stated "it felt like someone punched me in the arm."
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date during 2015, the patient was inoculated at a hospital with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On an unknown date in 2016, the patient was treated by a physician for a severe vesicular outbreak, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events is unknown. Additional information has been requested.
Redness, swelling, itching approximately 1 1/2 in diameter at injection site. Pt. reports mild swelling 3/26/16 a.m. and increased swelling 3/27/16 a.m. Given ibuprofen and ice. to continued as needed until swelling resolves.
Sciatic nerve got damaged, it was very severe; Sweating a lot now; has a lot of pain that is very severe; his blood pressure is very high; His sugar is very unbalanced; Nausea; vomits, stomach problems; vomits, stomach problems; muscular pain very severe; Dizziness; feels a lot of like chills in his body; urinary problems, he no longer has control of bladder; Not able to sleep; sometimes feels like his heart wants to get out, not able to breathe; sometimes feels like his heart wants to get out, not able to breathe; Fatigue; he did receive effects very, very bad.; cramps in his stomach very severe.; The second vaccine, the rash is more bigger in the chest.; headache; shaking; but they got worse after the vaccine.; This is a spontaneous report from a contactable consumer (patient). A 60-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: was not reported), via an unspecified route of administration on an unspecified date (age at the time of vaccination 60-years-old), as a single dose for COVID-19 immunization. The patient medical history included Depression, Panic attack, Blood pressure high, Diabetes mellitus, Blood sugar problems, Chronic insomnia, and Thyroid problems. The patient concomitant medication included Synthroid taken for thyroid problems. Patient previously received first dose of BNT162B2 vaccine, via an unspecified route of administration on an unspecified date (age at the time of vaccination 60-years-old), as a single dose for COVID-19 immunization and experienced little fatigue and little rash. On an unspecified date, the patient experienced Sciatic nerve got damaged, it was very severe; Sweating a lot now; has a lot of pain that is very severe; his blood pressure is very high; His sugar is very unbalanced; Nausea; vomits, stomach problems; muscular pain very severe; Dizziness; feels a lot of like chills in his body; urinary problems, he no longer has control of bladder; Not able to sleep; sometimes feels like his heart wants to get out, not able to breathe; Fatigue; he did receive effects very, very bad; cramps in his stomach very severe; The second vaccine, the rash is more bigger in the chest; headache; shaking; and but they got worse after the vaccine. On an unspecified date, the patient underwent lab tests and procedures which included Blood glucose: Unbalanced, Sugar is very unbalanced; and Blood pressure measurement: very high, blood pressure is very high. Patient clarifies he has taken everything for panic attacks, Ibuprofen, and it's not working. Patient went to pharmacy where they gave him some Benadryl cream, he put the cream on his chest and the rash disappeared. The outcome of the event the second vaccine, the rash is more bigger in the chest was recovered on an unspecified date; and all other events was unknown.  The lot number for [BNT162B2] was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101171811 same reporter/patient/product, different dose/event.
Post vaccination patient reports tightness in the throat, chest, and nausea. Patient was taken for observation . Reports numbness in legs  and feels "fogy:. Emergency contact was notified. Vital at 1048am Pulse 62 BP 122/91 RESP 16 spO2 99%. Patient request to go outside for fresh air. Refuse  transportation to ER for further evaluation. Patient is stable and is ambulating, and reports she is feeling better.  Patient dispositioned by herself.
I felt like I had covid again; A whole night of not sleeping; Head hurt; My body hurt; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION COMPLICATION (I felt like I had covid again), INSOMNIA (A whole night of not sleeping), HEADACHE (Head hurt) and MYALGIA (My body hurt) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION COMPLICATION (I felt like I had covid again), INSOMNIA (A whole night of not sleeping), HEADACHE (Head hurt) and MYALGIA (My body hurt). At the time of the report, VACCINATION COMPLICATION (I felt like I had covid again), INSOMNIA (A whole night of not sleeping), HEADACHE (Head hurt) and MYALGIA (My body hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.
Beginning approximately 12 hours after vaccine, I had fever of 101.5, severe headache, severe joint/leg/back pain, shortness of breath and severe lethargy. Basically, I felt like I was having covid all over again.
This is a spontaneous report from a contactable physician. A 18-year-old patient of an unspecified race/ethnicity and gender received TRUMENBA, via an unspecified route of administration, on an unspecified date, at single dose, for immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced extreme pain on the site of the injection 5 hours after vaccination. The day after the patient experienced 102 temperature, extreme joint pain. The patient underwent lab tests and procedures which included body temperature (unspecified date): 102. Therapeutic measures were taken as a result of pyrexia and included treatment with Tylenol. The outcome of the events was unknown. No follow-up attempts possible. No further information expected.
Really dizzy; Really nauseous; Felt like weakness in her arms and legs; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 27-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot/batch number: EN6202 and expiry date was not reported), via an unspecified route of administration in arm left, on 26Feb2021 at 08:00 (at the age of 27-year-old), as a dose 1, single for COVID-19 immunization. The patient's medical history includes allergy to morphine probably around 2018, when she had her son. The patient stated that she had no reactions to vaccinations. It was reported that on an unspecified date in Jul2020 the patient had COVID and due to having COVID the patient developed really bad allergies that sometimes make it hard for her to breathe, but nothing else that she was aware of. The patient concomitant medication includes mepyramine maleate, pamabrom, paracetamol (Pamprin) (Start: Unknown Stop: Unknown) for cramps. Reportedly within four weeks prior to the first administration date of the suspect vaccine the patient did not receive any other vaccine. On 26Feb2021, probably around 5 hours after being administered the vaccine, around 13:00, the patient felt fine almost all morning but then she felt really dizzy, really nauseous and felt like weakness in her arms and legs and she could still hold things and stuff. She wanted to make sure that these are normal reactions to the vaccine, or if they are serious events, and if she should follow-up with doctor or medical attention. The clinical outcome of all the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Narrative:  Patient with known anxiety disorder presented to Covid Vaccination clinic concerned about getting the vaccination. After much discussion patient decided to have vaccination. Patient monitored 15 minutes as per protocol and nurse approached him to ask how he was feeling as he looked anxious. Patient reports that he is anxious and has some dizziness. Vitals obtained. 1522: BP190/92 p62, 1530: BP 191/90 p 62, 1545:206/96 p62. Dizziness slightly improved. Patient at first refused water and a snack, but later did have apple juice. At 1615 patients BP still elevated. Patient reports he was told by PCP to d/c Lisinopril 20mg and he has been taking antihistamines for past 3 days for anxiety. EMS was called to evaluate patient. BP on manual cuff was 186/61. Patient and EMS team discussed risks of patient driving home. Patient decided to drive home and f/up with PCP. Staff at clinic consulted patients PCP and an On Call MD regarding patients symptoms. PCP felt that the episode of hypertension was related to patients anxiety.
Extreme pain in shoulder which began within hours of injection (SIRVA) and continues intermittently.  MRI is negative.
Sore arm for several days from vaccine #1.  Chills, muscle aches, nausea, headache, fatigue, sore arm starting 1/2 day after vaccine #2.  Continued feeling poorly for 1 1/2 days, a little better the following day, much improvement on the 3rd day.
Patient called on 5/13 and stated that approximately one week following his second moderna dose he was experiencing myalgia, fatigue, confusion, lack of concentration, headache (though headache is resolving). I advised him to follow up with his healthcare provider, and he stated that he would.
This spontaneous report was received from a registered nurse concerning to a 60 year old male patient. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 24-JAN-1996, the patient was vaccinated with the first dose reported as " only one dose" of M-M-R II, HSA diluted in sterile diluent for pre-employment vaccination (prophylaxis) (the lot #, expiration date, route, strength and the dose were not provided). On 12-MAY-2017, due to a local measles outbreak, the patient had a titers test which was negative for mumps, but was positive for measles and rubella. The reporter nurse did not know why the patient only received 1 dose of the vaccine. However, the patient was healthy, and had not experienced any other adverse effects. There was no product quality complaint (PQC) involved. The outcome of the event and the causal relationship between the events and the vaccine were unknown. This is one of two reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1705USA009249: Original Case: 1705USA008462.
her arm hurt; felt lightheaded; This is a spontaneous report from a contactable consumer or other non hcp (patient). An 84-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 04Feb2021 (at the age of 84-year-old) at dose 1, single for covid-19 immunisation. Medical history and concomitant medications were not reported. On an unspecified date in 2021 the patient experienced her arm hurt, felt lightheaded. 84-year-old consumer would like to report that after receiving the Pfizer Vaccine (Pfizer-BioNTech COVID-19 vaccine) she only had very little side effects: The first day her arm hurt in the evening for just 1 or 2 hours. She felt lightheaded only for 2 days in the morning. Her first dose was administered on 04Feb2021. Reporter was grateful for having experienced only minimal Adverse Reactions to the Pfizer-BioNTech COVID-19 vaccine. Outcome of the events was unknown.  Information on about lot/batch number has been requested.  Follow-up (31Mar2021): Follow-up attempts are completed. No further information is expected.